IMU PD1-Vaxx Clinical Trial Supply Agreement with Roche 28/01/22 PRICE SENSITIVE download Created with Sketch. 107.17KB Share IMU HER-Vaxx Immunotherapy Patent Granted in Europe 28/01/22 PRICE SENSITIVE download Created with Sketch. 123.17KB Share IMU Imugene Receives $6.54 million R&D Tax Incentive 06/01/22 PRICE SENSITIVE download Created with Sketch. 83.04KB Share IMU South Korea HERVaxx Patent Grant 06/01/22 PRICE SENSITIVE download Created with Sketch. 94.04KB Share IMU Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx 04/01/22 PRICE SENSITIVE download Created with Sketch. 96.13KB Share IMU FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX 13/12/21 PRICE SENSITIVE download Created with Sketch. 177.59KB Share IMU FDA IND APPROVAL FOR ONCOLYTIC VIROTHERAPY VAXINIA 13/12/21 PRICE SENSITIVE download Created with Sketch. 127.52KB Share IMU Update on Clinical Trial of Oncolytic Virotherapy CHECKvacc 07/12/21 PRICE SENSITIVE download Created with Sketch. 158.38KB Share IMU S&P DJI Announces December 2021 Quarterly Rebalance 03/12/21 PRICE SENSITIVE download Created with Sketch. 92.25KB Share IMU Clinical Trial Supply Agreement with Merck KGaA and Pfizer 16/11/21 PRICE SENSITIVE download Created with Sketch. 124.99KB Share IMU Investor Presentation Imugene Eureka Therapeutics 01/11/21 PRICE SENSITIVE download Created with Sketch. 2.22MB Share IMU Imugene and Eureka Therapeutics onCARlytics Collaboration 01/11/21 PRICE SENSITIVE download Created with Sketch. 145.54KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 22/10/21 PRICE SENSITIVE download Created with Sketch. 3.24MB Share IMU FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF CHECKVACC 20/10/21 PRICE SENSITIVE download Created with Sketch. 104.78KB Share IMU Imugene HER-Vaxx Immunotherapy Patent Granted in Japan 22/09/21 PRICE SENSITIVE download Created with Sketch. 145.67KB Share IMU S&P DJI Announces September 2021 Quarterly Rebalance 03/09/21 PRICE SENSITIVE download Created with Sketch. 108.28KB Share IMU Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials 01/09/21 PRICE SENSITIVE download Created with Sketch. 151.61KB Share IMU Appendix 4E and Full Year Statutory Accounts 30/08/21 PRICE SENSITIVE download Created with Sketch. 1.95MB Share IMU Phase 1 Clinical Trial Update of Immunotherapy PD1-Vaxx 27/08/21 PRICE SENSITIVE download Created with Sketch. 141.61KB Share IMU Response to ASX Query 23/08/21 PRICE SENSITIVE download Created with Sketch. 242.77KB Share IMU Research partnership with Celularity for solid tumors 05/08/21 PRICE SENSITIVE download Created with Sketch. 205.02KB Share IMU Prospectus for SPP and Placement Options Offer 29/07/21 PRICE SENSITIVE download Created with Sketch. 462.85KB Share IMU Imugene completes $90 M placement and launches $5 M SPP 29/07/21 PRICE SENSITIVE download Created with Sketch. 171.33KB Share IMU Trading Halt 27/07/21 PRICE SENSITIVE download Created with Sketch. 179.35KB Share IMU Appendix 4C - Quarterly Report 23/07/21 PRICE SENSITIVE download Created with Sketch. 404.23KB Share IMU FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC 02/07/21 PRICE SENSITIVE download Created with Sketch. 133.12KB Share IMU Investor Presentation 18/05/21 PRICE SENSITIVE download Created with Sketch. 3.1MB Share IMU IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS 18/05/21 PRICE SENSITIVE download Created with Sketch. 150.1KB Share IMU Prestigious Research Journal Publish HER-Vaxx Phase 1B Data 29/04/21 PRICE SENSITIVE download Created with Sketch. 124.23KB Share IMU Appendix 4C - quarterly 23/04/21 PRICE SENSITIVE download Created with Sketch. 329.82KB Share IMU Imugene announces clinical milestone for HER-Vaxx 21/04/21 PRICE SENSITIVE download Created with Sketch. 125.23KB Share IMU Imugene Oncolytic Virus Presentation at AACR 2021 Meeting 12/04/21 PRICE SENSITIVE download Created with Sketch. 102.64KB Share IMU Imugene HER-Vaxx Presentation at AACR 2021 Meeting 12/04/21 PRICE SENSITIVE download Created with Sketch. 128KB Share IMU Final Highest Dose in Phase 1 Clinical Trial of PD-VAXX 07/04/21 PRICE SENSITIVE download Created with Sketch. 131.8KB Share IMU S&P DJI Announces March 2021 Quarterly Rebalance 12/03/21 PRICE SENSITIVE download Created with Sketch. 183.24KB Share IMU Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting 11/03/21 PRICE SENSITIVE download Created with Sketch. 122.7KB Share IMU Half Yearly Report and Accounts 26/02/21 PRICE SENSITIVE download Created with Sketch. 6.16MB Share IMU Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX Trial 12/02/21 PRICE SENSITIVE download Created with Sketch. 124.85KB Share IMU Appendix 4C - quarterly 29/01/21 PRICE SENSITIVE download Created with Sketch. 272.19KB Share IMU Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial 21/01/21 PRICE SENSITIVE download Created with Sketch. 126.73KB Share IMU IMUGENE COMPLETES RECRUITMENT TO HER-VAXX PHASE 2 TRIALIM 07/01/21 PRICE SENSITIVE download Created with Sketch. 107.46KB Share IMU Imugene Enrols First Cohort of PD1-Vaxx Clinical Trial 17/12/20 PRICE SENSITIVE download Created with Sketch. 136.02KB Share IMU Imugene Receives $4.82 million R&D Tax Incentive 10/12/20 PRICE SENSITIVE download Created with Sketch. 129.13KB Share IMU Imugene First Patient Dosed in PD1-VAXX Clinical Trial 01/12/20 PRICE SENSITIVE download Created with Sketch. 120.02KB Share IMU Imugene HER Vaxx shows positive Overall Survival in trial 23/11/20 PRICE SENSITIVE download Created with Sketch. 134.83KB Share IMU Imugene Receives FDA IND Approval for PD1-VAXX Trial in USA 02/11/20 PRICE SENSITIVE download Created with Sketch. 111.65KB Share IMU Appendix 4C - quarterly 27/10/20 PRICE SENSITIVE download Created with Sketch. 366.05KB Share IMU Imugene Immunotherapy Combination Patent Granted in US 02/10/20 PRICE SENSITIVE download Created with Sketch. 133.51KB Share IMU Imugene Secures $5.7 million Option Underwriting Agreement 09/09/20 PRICE SENSITIVE download Created with Sketch. 144.01KB Share IMU Imugene Receives PD1-VAXX Ethics Trial Approval in USA 03/09/20 PRICE SENSITIVE download Created with Sketch. 143.66KB Share IMU Appendix 4E & Annual Report to shareholders 31/08/20 PRICE SENSITIVE download Created with Sketch. 4.81MB Share IMU Imugene Receives Third PD1-VAXX Ethics Trial Approval 21/08/20 PRICE SENSITIVE download Created with Sketch. 126.29KB Share IMU Imugene Receives Clinical Guidance from US FDA for Vaxinia 06/08/20 PRICE SENSITIVE download Created with Sketch. 142.12KB Share IMU Appendix 4C - quarterly 27/07/20 PRICE SENSITIVE download Created with Sketch. 408.9KB Share IMU Imugene Receives Second PD1-VAXX Ethics Trial Approval 17/07/20 PRICE SENSITIVE download Created with Sketch. 145.69KB Share IMU Imugene Receives Ethics Approval to Start PD1-VAXX Trial 14/07/20 PRICE SENSITIVE download Created with Sketch. 145.97KB Share IMU Imugene HER-Vaxx Phase 2 Clinical Update 04/05/20 PRICE SENSITIVE download Created with Sketch. 114.71KB Share IMU Appendix 4C - quarterly 24/04/20 PRICE SENSITIVE download Created with Sketch. 684.52KB Share IMU Half Yearly Report and Accounts 26/02/20 PRICE SENSITIVE download Created with Sketch. 5.84MB Share IMU Appendix 4C - quarterly 31/01/20 PRICE SENSITIVE download Created with Sketch. 348.47KB Share IMU Imugene PD1-Vaxx Immunotherapy Update 28/01/20 PRICE SENSITIVE download Created with Sketch. 138.09KB Share IMU Imugene HER-Vaxx Immunotherapy Patent Granted in US 14/01/20 PRICE SENSITIVE download Created with Sketch. 123.55KB Share IMU Prospectus 02/12/19 PRICE SENSITIVE download Created with Sketch. 556.91KB Share IMU Imugene Share Placement to raise $24.6 million 02/12/19 PRICE SENSITIVE download Created with Sketch. 134.16KB Share IMU Trading Halt 28/11/19 PRICE SENSITIVE download Created with Sketch. 360.08KB Share IMU Imugene Receives $4.13 million R&D Tax Incentive 04/11/19 PRICE SENSITIVE download Created with Sketch. 103.43KB Share IMU Appendix 4C - quarterly 25/10/19 PRICE SENSITIVE download Created with Sketch. 389.27KB Share IMU US Defense Grant to Study Imugene CF33 Oncolytic Virotherapy 23/10/19 PRICE SENSITIVE download Created with Sketch. 246.29KB Share IMU CF33 Oncolytic Virus Clinical Trial Program Update 21/10/19 PRICE SENSITIVE download Created with Sketch. 86.78KB Share IMU Comprehensive Phase Ib HER-Vaxx Results Presented at ESMO 01/10/19 PRICE SENSITIVE download Created with Sketch. 156.74KB Share IMU Appendix 4E & Annual Report to shareholders 30/08/19 PRICE SENSITIVE download Created with Sketch. 5.25MB Share IMU Appendix 4C - quarterly 26/07/19 PRICE SENSITIVE download Created with Sketch. 247.66KB Share IMU Investor Presentation - Proposed Acquisition 15/07/19 PRICE SENSITIVE download Created with Sketch. 7.06MB Share IMU Imugene Enhances Portfolio with Compelling Oncolytic Virus 15/07/19 PRICE SENSITIVE download Created with Sketch. 91.67KB Share IMU New HER-Vaxx Cancer Vaccine trial data presented at ESMO GI 08/07/19 PRICE SENSITIVE download Created with Sketch. 79.11KB Share IMU Appendix 4C - Quarterly and Business Update 16/04/19 PRICE SENSITIVE download Created with Sketch. 270.77KB Share IMU IMU presents new mimotope PD-1 vaccine data at AACR 03/04/19 PRICE SENSITIVE download Created with Sketch. 160.49KB Share IMU IMU presents new KEY-Vaxx and B-Vaxx data at AACR 02/04/19 PRICE SENSITIVE download Created with Sketch. 164.88KB Share IMU IMU presents positive new HER-Vaxx data at AACR 02/04/19 PRICE SENSITIVE download Created with Sketch. 167.49KB Share IMU IMU Pre-IND FDA Meeting Provides Guidance for KEY-Vaxx 20/03/19 PRICE SENSITIVE download Created with Sketch. 75.86KB Share IMU Imugene doses first patient in HER-Vaxx phase 2 trial 14/03/19 PRICE SENSITIVE download Created with Sketch. 96.99KB Share IMU IMU Announces Presentations on KEY-Vaxx and B-Vaxx at AACR 04/03/19 PRICE SENSITIVE download Created with Sketch. 100.39KB Share IMU Half Yearly Report and Accounts 28/02/19 PRICE SENSITIVE download Created with Sketch. 4.58MB Share IMU Pause in Trading 28/02/19 PRICE SENSITIVE download Created with Sketch. 116KB Share IMU Imugene Announces Presentation on HER-Vaxx at the AACR 2019 28/02/19 PRICE SENSITIVE download Created with Sketch. 85.19KB Share IMU Appendix 4C - Quarterly and Business Update 30/01/19 PRICE SENSITIVE download Created with Sketch. 557.58KB Share IMU Investor Presentation 10/01/19 PRICE SENSITIVE download Created with Sketch. 11.83MB Share IMU IMU Meets Endpoints in Phase 1b Gastric Cancer Trial 17/12/18 PRICE SENSITIVE download Created with Sketch. 114.47KB Share IMU Imugene Advances to Phase 2 in Gastric Cancer Trial 13/11/18 PRICE SENSITIVE download Created with Sketch. 366.09KB Share IMU Imugene Receives $1.85 million R&D Tax Incentive 09/11/18 PRICE SENSITIVE download Created with Sketch. 101.15KB Share IMU Appendix 4C - quarterly 30/10/18 PRICE SENSITIVE download Created with Sketch. 1.05MB Share IMU Imugene commences cGMP manufacture of PD-1 cancer vaccine 21/09/18 PRICE SENSITIVE download Created with Sketch. 141.95KB Share IMU Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment 11/09/18 PRICE SENSITIVE download Created with Sketch. 393.79KB Share IMU Appendix 4E and Audited Financial Report 31/08/18 PRICE SENSITIVE download Created with Sketch. 539.83KB Share IMU Appendix 4C - Quarterly and Business Update 31/07/18 PRICE SENSITIVE download Created with Sketch. 555.82KB Share IMU PD-1 cancer vaccine development update 23/07/18 PRICE SENSITIVE download Created with Sketch. 399.17KB Share IMU Response to ASX Query 08/06/18 PRICE SENSITIVE download Created with Sketch. 496.2KB Share IMU Prospectus 07/06/18 PRICE SENSITIVE download Created with Sketch. 976.05KB Share IMU IMUGENE RAISES $20.1 MILLION 07/06/18 PRICE SENSITIVE download Created with Sketch. 584.16KB Share IMU Imugene Licences Extensive B-Cell Immuno-Oncology Portfolio 07/06/18 PRICE SENSITIVE download Created with Sketch. 341.69KB Share